Pub. Date : 2014 Feb-Apr
PMID : 24566025
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | In the presence of EGFR mutation or ALK rearrangement, specific inhibitors have shown superior efficacy to chemotherapy in first-line treatment for anti-EGFR (erlotinib and gefitinib) and in second-line treatment for anti-ALK (crizotinib). | Erlotinib Hydrochloride | ALK receptor tyrosine kinase | Homo sapiens |